Granulomatosis with polyangiitis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 26: Line 26:


===Gender===
===Gender===
Males are more commonly affected with granulomatosis with polyangiitis. The overall male to female ratio is approximately 1.2 to 1. However, this ratio varies based on the geographical location.<ref name="pmid24932888">{{cite journal| author=Catanoso M, Macchioni P, Boiardi L, Manenti L, Tumiati B, Cavazza A et al.| title=Epidemiology of granulomatosis with polyangiitis (Wegener's granulomatosis) in Northern Italy: a 15-year population-based study. | journal=Semin Arthritis Rheum | year= 2014 | volume= 44 | issue= 2 | pages= 202-7 | pmid=24932888 | doi=10.1016/j.semarthrit.2014.05.005 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24932888  }} </ref>  
Males are more commonly affected with granulomatosis with polyangiitis. The overall male to female ratio is approximately 1.2 to 1. However, the ratio varies depending on geographical location.<ref name="pmid24932888">{{cite journal| author=Catanoso M, Macchioni P, Boiardi L, Manenti L, Tumiati B, Cavazza A et al.| title=Epidemiology of granulomatosis with polyangiitis (Wegener's granulomatosis) in Northern Italy: a 15-year population-based study. | journal=Semin Arthritis Rheum | year= 2014 | volume= 44 | issue= 2 | pages= 202-7 | pmid=24932888 | doi=10.1016/j.semarthrit.2014.05.005 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24932888  }} </ref>


===Race===
===Race===

Revision as of 15:56, 31 October 2016

Granulomatosis with polyangiitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Granulomatosis with polyangiitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Granulomatosis with polyangiitis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Granulomatosis with polyangiitis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Granulomatosis with polyangiitis epidemiology and demographics

CDC on Granulomatosis with polyangiitis epidemiology and demographics

Granulomatosis with polyangiitis epidemiology and demographics in the news

Blogs on Granulomatosis with polyangiitis epidemiology and demographics

Directions to Hospitals Treating Granulomatosis with polyangiitis

Risk calculators and risk factors for Granulomatosis with polyangiitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]Cafer Zorkun, M.D., Ph.D. [4]

Overview

The prevalence of Granulomatosis with polyangiitis in Europe ranges from 23.7 to 160 per million person a year, with higher prevalence rates found in northern European countries such as Norway, southern Sweden, northern Germany and the United Kingdom. The incidence of the disease is 2.4 cases per million per year, with higher incidences found in Norway, Sweden, Germany, and the United Kingdom.[1]

Epidemiology

Prevalence

The prevalence of Granulomatosis with polyangiitis in Europe ranges from 23.7 to 160 per million persons.[1]

Incidence

The incidence of Granulomatosis with polyangiitis in Europe ranges from 3 to 14.4 per million per year.[1] The incidence of Granulomatosis with polyangiitis in children ranges form 0.03 to 3.2 per 100,000 per year.[2]

Demographics

The age, sex, and race distribution of Granulomatosis with polyangiitis is dictated by the prevalence of the underlying cause within those demographic groups.

Age

The mean age of diagnosis of granulomatosis with polyangiitis is 58 years. The incidence of the disease in female patients is 70 to 79 years of age and in male patients older than 80 years.[1] The disease most commonly presents in patients that are either middle aged or elderly.[3] [4] [5] The mean age of diagnosis of Granulomatosis with polyangiitis in children is between the ages of 4 to 17. However, the disease is rarely seen in children.[2]

Gender

Males are more commonly affected with granulomatosis with polyangiitis. The overall male to female ratio is approximately 1.2 to 1. However, the ratio varies depending on geographical location.[1]

Race

Granulomatosis with polyangiitis usually affects individuals of the Caucasian race. Other races can be affected but have a lower prevalence rate to develop Granulomatosis with polyangiitis. [1] [6]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Catanoso M, Macchioni P, Boiardi L, Manenti L, Tumiati B, Cavazza A; et al. (2014). "Epidemiology of granulomatosis with polyangiitis (Wegener's granulomatosis) in Northern Italy: a 15-year population-based study". Semin Arthritis Rheum. 44 (2): 202–7. doi:10.1016/j.semarthrit.2014.05.005. PMID 24932888.
  2. 2.0 2.1 Cabral DA, Uribe AG, Benseler S, O'Neil KM, Hashkes PJ, Higgins G; et al. (2009). "Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood". Arthritis Rheum. 60 (11): 3413–24. doi:10.1002/art.24876. PMID 19877069.
  3. Koldingsnes W, Nossent H (2000). "Epidemiology of Wegener's granulomatosis in northern Norway". Arthritis Rheum. 43 (11): 2481–7. doi:10.1002/1529-0131(200011)43:11<2481::AID-ANR15>3.0.CO;2-6. PMID 11083271.
  4. Watts RA, Lane SE, Bentham G, Scott DG (2000). "Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom". Arthritis Rheum. 43 (2): 414–9. doi:10.1002/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0. PMID 10693883.
  5. Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J, Rodriguez-Ledo P, Llorca J (2003). "The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions". Arthritis Rheum. 49 (3): 388–93. doi:10.1002/art.11115. PMID 12794795.
  6. Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M (2007). "Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden". Rheumatology (Oxford). 46 (8): 1329–37. doi:10.1093/rheumatology/kem107. PMID 17553910.

Template:WikiDoc Sources